首页> 外国专利> method for detection and mitigation of the risk for breast cancer by the micronucleus test in zweikernigen cells

method for detection and mitigation of the risk for breast cancer by the micronucleus test in zweikernigen cells

机译:用微核试验检测和降低茨维克氏原细胞中乳腺癌风险的方法

摘要

Determining the risk of developing breast cancer based on spontaneous development of micronuclei in mitogen-treated lymphocyte cultures, is new. Method for determining the risk of developing breast cancer comprising: (a) establishing a lymphocyte culture from heparin-treated peripheral blood; (b) mitogenic stimulation within 6 hours of establishing the culture; (c) adding a cytokinesis inhibitor 40-50 hours after establishment; (d) interrupting culture 12-24 hours after (c) by centrifuging, hypotonic treatment then preparation of a fixed cell suspension; (e) making a cytological preparation; (f) determining the micronucleus rate (MNR) in binuclear cells; and (g) determining the risk by comparing spontaneous MNR in the test sample with that in controls.
机译:基于有丝分裂原处理的淋巴细胞培养物中微核的自发发展来确定患乳腺癌的风险是新的。确定罹患乳腺癌的风险的方法,包括:(a)从肝素治疗的外周血建立淋巴细胞培养物; (b)在培养开始后6小时内进行有丝分裂刺激; (c)在建立后40-50小时加入细胞分裂抑制剂; (d)在(c)之后12-24小时通过离心,低渗处理然后制备固定的细胞悬浮液来中断培养; (e)进行细胞学准备; (f)确定双核细胞中的微核率(MNR); (g)通过将测试样品中的自然MNR与对照中的自然MNR进行比较来确定风险。

著录项

  • 公开/公告号DE50312427D1

    专利类型

  • 公开/公告日2010-04-01

    原文格式PDF

  • 申请/专利权人 VOGEL WALTER;

    申请/专利号DE20035012427T

  • 发明设计人 VOGEL WALTER;

    申请日2003-10-08

  • 分类号G01N33/50;C12Q1/68;G01N33/574;

  • 国家 DE

  • 入库时间 2022-08-21 18:27:42

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号